Delivery Order SPE2DR25D1109-SPE2DR26FFF3P
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $8,908.09 by the Defense Logistics Agency for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,684.94 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $55,198.97 by the Defense Logistics Agency (DLA) for the supply of Jardiance 25 mg tablets (90-count packaging). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded through open competition. The ultimate completion date is September 23, 2025, with the award issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $17,412.62 for 90 tablets of Jardiance 25 mg by the Defense Logistics Agency (DLA). This competitively awarded, firm fixed-price delivery order is set to be completed by October 17, 2025, and represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets in a 90-count quantity. This firm fixed-price contract, awarded on July 17, 2025, carries a ceiling value of $9,648.60 and is scheduled for ultimate completion by July 18, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a firm fixed price ceiling value of $4,328.80 and an ultimate completion date of August 8, 2025. This award represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 19, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract value of $2,935.98. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a non-competitive, non-set-aside award. The delivery will be fulfilled at the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 90-count bottles of Jardiance 10 mg tablets, valued at $22,225.71. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation and represents a continuation of the vendor's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $8,158.93 on August 21, 2025, for the supply of Jardiance 25 mg tablets (90 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The company serves as a critical vendor for federal medical...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF3PDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $30,051.78 by the Defense Logistics Agency on October 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation and is scheduled for completion by October 21, 2025, with performance at the company's Conshohocken facility. This delivery order exemplifies AmerisourceBergen's critical role in the Defense Logistics Agency's Medical Supply Chain, which supports military and veteran healthcare systems with comprehensive pharmaceutical products. Jardiance is an antidiabetic medication commonly used within federal healthcare programs to manage type 2 diabetes across the Defense Health Agency and other government medical facilities. The award reflects AmerisourceBergen's proven capability to fulfill federal pharmaceutical procurement requirements through open competition and demonstrates the company's ongoing significance as a primary vendor for specialized medical commodities supporting military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.1k | 10/20/25 |